“ESCMID Guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli” is undergoing public consultation. Check here how to participate. The deadline to provide feedback and comments is 30 August 2021.

At the end of 2021, elections will be held among the membership to fill three (out of eight) positions in the ESCMID Executive Committee, one representing clinical microbiology and two infectious diseases.
ESCMID would like to encourage you to propose candidates by 31 August 2021 on the ESCMID website.

ESCMID supports 32 Study Groups that cover a wide array of topics and specialties in the fields of clinical microbiology and infectious diseases. Joining a Study Group is free and open to all ESCMID members and opens up many research and networking opportunities. Learn more about them and join on the ESCMID website.

This study aimed to determine the benefits and harms of discontinuing unnecessary antibiotic therapy for uncomplicated respiratory tract infections (RTI) when antibiotics are considered no longer necessary. It is a multicentre, open-label, randomised controlled clinical trial in primary care centres from 2017 to 2020.